Sort
51,593 grants matching “hepatitis”
VIRAL HEPATITIS IN CHILDREN OF INJECTION DRUG USERS
$372,406Johns Hopkins University · R01 · FY2000 · DA
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis
$372,404Mahmoud A Elsohly · Elsohly Laboratories, Inc. · R42 · FY2009 · AR
Drug Interactions in Substance Abusers with HIV Infection
$372,375Gerald H. Friedland · Yale University · R01 · FY2008 · DA
Drug Interactions in Substance Abusers with HIV Infection
$372,375Gerald H. Friedland · Yale University · R01 · FY2009 · DA
Mechanistic role of phosphatidylinositol 5-phosphate 4-kinase beta in GTP-dependent lysosomal acidification for stress-resilient cell growth and metabolism
$372,318Atsuo Sasaki · University Of Cincinnati · R01 · FY2023 · GM
Reinvigorating HIV Prevention and Care for People Who Use Drugs: Accelerating Progress and Sustaining Gains in the Midst of Societal Disruption
$372,315Holly C. Hagan · New York University · P30 · FY2023 · DA
Exploring the use of conplastic mice as a model of risk stratification of coronavirus susceptibility
$372,259Doris A Germain · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Lower Vulnerability to Toxins in Aging by Treatment with Lipoic Acid
$372,254Tory M Hagen · Oregon State University · P01 · FY2011 · AT
Antiviral immunity directed by virus-derived small silencing RNAs in mice
$372,210Shou-Wei Ding · University Of California Riverside · R56 · FY2015 · AI
Viral kinetic models of HCV clearance in hemophiliacs treated with telaprevir
$372,151Kenneth E Sherman · University Of Cincinnati · R34 · FY2012 · HL
Regulation of Hepatic P450s by Anti-Cholesterol Drugs
$372,149Thomas A Kocarek · Wayne State University · R01 · FY2014 · HL
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
$372,131Univ Of Massachusetts Med Sch Worcester · N01 · FY2000 · DK
CYP2B6 inhibitors perturb proper distribution of lipids leading to obesity and fatty liver disease
$372,110William S Baldwin · Clemson University · R15 · FY2020 · ES
Mitochondrial Diabetes & Manganic Porphyrin Treatment
$372,100Douglas C Wallace · University Of California-Irvine · R01 · FY2006 · DK
APOLIPOPROTEIN VARIATION AND HUMAN DISEASE
$372,088Boston University Medical Campus · R01 · FY2003 · HL
Clinical Addiction Research and Education (CARE) Program
$372,077Jeffrey H Samet · Boston Medical Center · R25 · FY2024 · DA
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
$372,013Natalia Nieto · University Of Illinois At Chicago · U01 · FY2015 · AA
The North Carolina Hepatitis Beta Clinical Research Network
$372,007Michael W Fried · Univ Of North Carolina Chapel Hill · U01 · FY2012 · DK
Mechanisms of CYP3A induction during pergnancy
$372,001Jashvant D Unadkat · University Of Washington · P01 · FY2016 · DA
HBV HIV Coinfection Research Network
$372,000Richard K. Sterling · Virginia Commonwealth University · R01 · FY2017 · DK
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS
$371,986Southwest Foundation For Biomedical Res · R01 · FY2001 · AI
HCV Replication and Immune Response in HIV Coinfection
$371,970University Of Washington · R01 · FY2001 · AI
Modeling TH17 Cells in Acute GVHD
$371,962Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R56 · FY2010 · AI
MECHANISMS FOR FETAL HEPATIC PROGRAMMING IN THE NON-HUMAN PRIMATE (NHP)
$371,956Jacob E Friedman · University Of Colorado Denver · R01 · FY2010 · DK
Joubert syndrome and related disorders of hindbrain development
$371,952Daniel Doherty · University Of Washington · R01 · FY2010 · NS